Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Malaria vaccine

S K Khurana1, V H Talib

  • 1Department of Laboratory Medicine, Safdarjang Hospital, New Delhi.

Indian Journal of Pathology & Microbiology
|December 1, 1996
PubMed
Summary
This summary is machine-generated.

Developing a malaria vaccine faces challenges, but progress is being made with candidate antigens like MSP-1 and AMA-1. Early trials show promise for transmission-blocking vaccines, offering hope for future malaria control strategies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Complete Genome Sequencing Reveals Unusual Equine Rotavirus A of Bat Origin from India.

Journal of virology·2022
Same author

Pilomatrixoma (calcifying Epithelioma of Malherbe and Chenantais) (A case report).

Indian journal of dermatology and venereology·2017
Same author

Humoral Immuno-deficiency in Lichen Planus.

Indian journal of dermatology, venereology and leprology·2017
Same author

Renomedullary Interstitial Cell tumor in a young lady: An incidental autopsy finding: A case report.

International journal of health sciences·2015
Same author

Study of C-reactive protein and C3 complement as acute phase reactants in unstable angina.

Journal of the Indian Medical Association·2014
Same author

Development of an antibody-ELISA for seroprevalence of Trypanosoma evansi in equids of North and North-western regions of India.

Veterinary parasitology·2013
Same journal

Prof Aseem Kumar Basu, MBBS, DTM and H, FRCPath (Lond), PhD (Lond), Fmr. Professor Department of Haematology, School of Tropical Medicine, Kolkata, India.

Indian journal of pathology & microbiology·2026
Same journal

Beyond the ordinary: Extramedullary hematopoiesis in an ossified psammomatous meningioma.

Indian journal of pathology & microbiology·2026
Same journal

Histomorphological spectrum of Adnexal Tumor with rippled pattern an unusual variant: Report of three cases.

Indian journal of pathology & microbiology·2026
Same journal

The shape-shifter: A case of pleomorphic giant cell carcinoma of prostate.

Indian journal of pathology & microbiology·2026
Same journal

Metachronous renal cell carcinoma with delayed testicular metastasis coexisting with synchronous prostatic adenocarcinoma.

Indian journal of pathology & microbiology·2026
Same journal

Cribriform-morular thyroid carcinoma with nodal metastasis: A diagnostic dilemma.

Indian journal of pathology & microbiology·2026
See all related articles

Area of Science:

  • * Malariology and Vaccinology: Focus on Plasmodium falciparum vaccine development.
  • * Immunology: Investigating host immune responses to parasite antigens.

Background:

  • * The concept of a multistage malaria vaccine is gaining traction due to shared parasite antigens across different life cycle stages.
  • * Several candidate asexual blood-stage antigens, including merozoite surface protein 1 (MSP-1), Serine Rich Antigen (SERA), Apical Membrane Antigen (AMA-1), and Erythrocyte Binding Antigen (EBA), have been identified and are under evaluation.
  • * Transmission-blocking vaccines targeting parasite stages in the mosquito, such as Pfs25, are also in development.

Purpose of the Study:

  • * To evaluate the progress and strategic development of asexual blood-stage malaria vaccine candidates.
  • * To assess the potential of transmission-blocking vaccines.
  • * To review the classical and novel approaches to malaria vaccine design, including antidisease vaccines.

Related Experiment Videos

Main Methods:

  • * Evaluation of approximately 20 asexual blood-stage candidate antigens by a TDR Task Force.
  • * Review of field study data, such as the SPf66 vaccine trial in Tanzanian children.
  • * Assessment of vaccine development strategies, including subunit vaccines (recombinant products or synthetic peptides).

Main Results:

  • * The SPf66 vaccine demonstrated safety, induced antibodies, and reduced clinical malaria risk by approximately 30% in a Tanzanian field study.
  • * Pfs25 antigen is a promising candidate for a transmission-blocking vaccine, with GMP-grade material produced for clinical trials.
  • * Malaria vaccine development presents a complex picture with achievements, setbacks, and ongoing controversies.

Conclusions:

  • * Despite challenges, the development of malaria vaccines, including those targeting blood stages and transmission, continues to be a critical global health objective.
  • * Novel approaches like antidisease vaccines offer alternative strategies to alleviate malaria morbidity.
  • * Continued research and commitment are essential to overcome the complexities and achieve effective malaria vaccines.